Wildgruber M, Stadlbauer T, Rasper M, Hapfelmeier A, Zelger O, Eckstein HH, Halle M, Rummeny EJ, Huber AM (2014)
Publication Type: Journal article
Publication year: 2014
Book Volume: 49
Pages Range: 728-734
Journal Issue: 11
DOI: 10.1097/RLI.0000000000000076
Objectives: The aim of this study was to compare the contrast-to-noise ratio (CNR) values of infarct and remote myocardium as well as infarct and blood after application of 0.1 mmol/kg gadobutrol and 0.1 mmol/kg gadobenate dimeglumine on late gadolinium enhancement magnetic resonance (MR) images. Material and Methods: The study was a prospective randomized controlled clinical study. After informed consent was obtained, 20 patients (12 men, 8 women; mean age, 67 ±11 years) with known chronic myocardial infarction were included for an intraindividual comparison of a single-dose gadobutrol and a single-dose gadobenate dimeglumine. Two MR imaging examinations were performed within a period of 28 days in a crossover design. Late gadolinium enhancement imaging was performed 10 minutes after gadolinium administration using a 2-dimensional phase-sensitive inversion recovery gradient echo sequence at 3 T. Infarct size, signal intensities (SIs), signal-to-noise ratio, and CNR were determined on phase-sensitive MR images. Values for CNR
APA:
Wildgruber, M., Stadlbauer, T., Rasper, M., Hapfelmeier, A., Zelger, O., Eckstein, H.H.,... Huber, A.M. (2014). Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T. Investigative Radiology, 49(11), 728-734. https://dx.doi.org/10.1097/RLI.0000000000000076
MLA:
Wildgruber, Moritz, et al. "Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T." Investigative Radiology 49.11 (2014): 728-734.
BibTeX: Download